Respiratory Tract Infection

Respiratory·MeSH: Respiratory Tract Infections

13 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Approved(12)

Drug	Company
amoxicillin	SUNSET ISLAND GROUP (SUN)
amoxicillin	Aptinyx Inc. (APTX)
Andrographolide	CHINA PHARMA HOLDINGS, INC. (CPHI)
Cefaclor Dispersible Tablets	CHINA PHARMA HOLDINGS, INC. (CPHI)
Cefalexin Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
Clarithromycin Granules and Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
Double - Coptis Suppository	China Health Industries Holdings, Inc. (CHHE)
Double-Coptis Suppository	China Health Industries Holdings, Inc. (CHHE)
erythromycin lactobionate	NEXUS BIOPHARMA INC (NEXS)
minocycline	NEXUS BIOPHARMA INC (NEXS)
tobramycin	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(1)

Drug	Company
nirsevimab	ASTRAZENECA PLC (AZN)

BioSniper tracks 13 drugs in development for Respiratory Tract Infection across 8 companies.

There are 1 clinical trial targeting Respiratory Tract Infection tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.